Alexandru Calin GRIGORESCU. Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations. Medical Science: Trends and Innovations Vol. 4, [S. l.], p. 86–93, 2025. DOI: 10.9734/bpi/msti/v4/4098. Disponível em: https://stm.bookpi.org/MSTI-V4/article/view/17124. Acesso em: 4 jun. 2026.